Code: 02599327
India and China have been identified by pharmaceutical companies as the future markets that would support drug research and development in a cost efficient manner. This has become necessary as resources to conduct clinical studies ... more
English
31.25 €
RRP: 36.71 €
You save 5.46 €

You get 76 loyalty points
Book synopsis
India and China have been identified by pharmaceutical companies as the future markets that would support drug research and development in a cost efficient manner. This has become necessary as resources to conduct clinical studies dwindle, coupled with the fact that pharmaceutical industries are under pressure to deliver quality medicine, on time, to the public. Exploring and examining India and China's potential in a stepwise fashion provides the opportunity to dissect the good, the bad and the ugly of globalization in a comparative approach. This paper will cover areas like ethics in the conduct of studies, good clinical practice (GCP), economic realities, ICH influence, intellectual property security and the role of government in global clinical trial.
Book details
Book category Books in English Economics, finance, business & management Business & management International business
31.25 €
English
Collection points Bratislava a 13192 dalších
Copyright ©2008-26 najlacnejsie-knihy.sk All rights reservedPrivacyCookies
26388 collection points
Delivery 2.99 €
02/210 210 99 (8-15.30h)Shopping cart ( Empty )